REG - Restore PLC - Issue of Equity

RestoreAnnouncement

14/01/2020 07:00

RNS Number : 6135Z
Restore PLC
14 January 2020
 


14 January 2020
 
Restore plc
 
("Restore" or the "Company")
 
Issue of Equity
 
 
Restore plc (AIM: RST) announces that following exercises made pursuant to the Company's share options scheme, it has issued and allotted 478,000 new ordinary shares of 5 pence each in the Company ("New Ordinary Shares").
 
Accordingly, application has been made for the New Ordinary Shares to be admitted to trading on AIM and it is expected that admission will become effective and that dealings will commence in the New Ordinary Shares at 08.00 a.m. on 16 January 2020 ("Admission").  The New Ordinary Shares will rank, pari-passu, with existing ordinary shares.
 
In accordance with the FCA's Disclosure Guidance and Transparency Rules (DTR 5.6.1R) the Company hereby notifies the market that immediately following Admission, its issued share capital will consist of 124,897,734 Ordinary Shares of 5 pence each, none of which are held in treasury. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
 
Restore plc                                                      www.restoreplc.com                      
Charles Bligh, Chief Executive Officer              020 7409 2420
Neil Ritchie, Chief Financial Officer
 
Peel Hunt LLP                                                 www.peelhunt.com
Mike Bell                                                           020 7418 8900
Ed Allsopp
 
Buchanan Communications                           www.buchanan.uk.com
Charles Ryland                                                  020 7466 5000
Vicky Hayns
Stephanie Watson




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEZZGMMMFDGGZM